Loading...

Understand KRAS and the Quest for Anti-Cancer Drugs

The KRAS oncogene is mutated in approximately ~30% of human cancers, and the targeting of KRAS has long been highlighted in many studies. Nevertheless, attempts to target KRAS directly have been ineffective. This review provides an overview of the structure of KRAS and its characteristic signaling p...

Full description

Saved in:
Bibliographic Details
Published in:Cells
Main Authors: Han, Chang Woo, Jeong, Mi Suk, Jang, Se Bok
Format: Artigo
Language:Inglês
Published: MDPI 2021
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8068306/
https://ncbi.nlm.nih.gov/pubmed/33917906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10040842
Tags: Add Tag
No Tags, Be the first to tag this record!